pamidronate has been researched along with Nephrotic Syndrome in 9 studies
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate can rarely cause (collapsing) focal segmental glomerular sclerosis with the nephrotic syndrome and renal insufficiency." | 4.88 | Renal complications from bisphosphonate treatment. ( Hirschberg, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ten Dam, MA | 1 |
| Hilbrands, LB | 1 |
| Wetzels, JF | 1 |
| Yoshizawa, H | 1 |
| Akimoto, T | 1 |
| Nishino, K | 1 |
| Inoue, M | 1 |
| Ito, C | 1 |
| Takeda, S | 1 |
| Kotoda, A | 1 |
| Tamba, K | 1 |
| Yumura, W | 1 |
| Muto, S | 1 |
| Ueda, Y | 1 |
| Kusano, E | 1 |
| Hirschberg, R | 1 |
| Kim, SD | 1 |
| Cho, BS | 1 |
| Nasr, SH | 1 |
| Preddie, DC | 1 |
| Markowitz, GS | 2 |
| Appel, GB | 1 |
| D'Agati, VD | 2 |
| Ramadan, KM | 1 |
| McKenna, KE | 1 |
| Morris, TC | 1 |
| Kuroki, A | 1 |
| Akizawa, T | 1 |
| Koshikawa, S | 1 |
| Fine, PL | 1 |
| Lockridge, L | 1 |
| Papac, RJ | 1 |
| Perazella, MA | 1 |
2 reviews available for pamidronate and Nephrotic Syndrome
| Article | Year |
|---|---|
Renal complications from bisphosphonate treatment.
Topics: Acute Kidney Injury; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Kidney; Kidney Diseases; Ne | 2012 |
[Drug-induced nephrotic syndrome].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antineoplastic Agents; Antirheumatic | 2007 |
1 trial available for pamidronate and Nephrotic Syndrome
| Article | Year |
|---|---|
Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy.
Topics: Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Male; Meth | 2006 |
6 other studies available for pamidronate and Nephrotic Syndrome
| Article | Year |
|---|---|
Nephrotic syndrome induced by pamidronate.
Topics: Adenocarcinoma; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Huma | 2011 |
Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Glomerulosclerosis, Focal S | 2011 |
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin | 2006 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bor | 2006 |
Nephrotic syndrome after treatment with pamidronate.
Topics: Aged; Antineoplastic Agents; Diphosphonates; Drug Administration Schedule; Female; Follow-Up Studies | 2002 |
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis.
Topics: Anti-Inflammatory Agents; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Kidney Tub | 2002 |